O'Connor RD, Gropler RJ, Peterson L, Schaffer J, Ackerman JJH. Limits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol.
J Pharm Biomed Anal 2007;
45:382-9. [PMID:
17931816 DOI:
10.1016/j.jpba.2007.08.022]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Academic Contribution Register] [Received: 03/09/2007] [Revised: 08/27/2007] [Accepted: 08/29/2007] [Indexed: 01/15/2023]
Abstract
Localized magnetic resonance spectroscopy (LMRS) promises a powerful non-invasive means to determine myocardial triacylglycerol (TAG) in a clinical setting. Here, the linearity, specificity, robustness, precision, and accuracy of an ex vivo mouse-heart LMRS TAG assay are assessed by quantifying the spatial, spectral, and relaxation-induced uncertainties. The protocol, which is based on localization by adiabatic selective refocusing (LASER) using frequency offset corrected inversion (FOCI) pulses, alternating gradient polarity, and simple post-processing, is shown to have good characteristics. The presented protocol has a benchmark, phantom-based, accuracy of 3%, and when applied to ex vivo mouse hearts the accuracy is 6%, making the LMRS assay comparable to the typical destructive bioanalytical assay.
Collapse